BRCA1 Tumor Suppression Depends on BRCT Phosphoprotein Binding, But Not Its E3 Ligase Activity

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993

Brca1 Controls Homology-Directed DNA Repair

Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245

Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis

Moynahan, M. E., & Jasin, M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2851 · Cited by 959

Centrosome Amplification and a Defective G2–M Cell Cycle Checkpoint Induce Genetic Instability in BRCA1 Exon 11 Isoform–Deficient Cells

Xu, X., Ohler, Z. W., Linke, S. P., Li, C., Gotay, J., Wang, X. W., Harris, C. C., Ried, T., & Deng, C. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80466-9 · Cited by 819

Identification of a RING protein that can interact in vivo with the BRCA1 gene product

Wu, L. C., Wang, Z. W., Tsan, J. T., Spillman, M. A., Phung, A., Xu, X. L., Yang, M.-C. W., Hwang, L.-Y., Bowcock, A. M., & Baer, R. J. (1996) · Nature Genetics · doi:10.1038/ng1296-430 · Cited by 743

The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.

Hakem, R., de la Pompa, J. L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81302-1 · Cited by 680

The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation

Hashizume, R., Fukuda, M., Maeda, I., Nishikawa, H., Oyake, D., Yabuki, Y., Ogata, H., & Ohta, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000881200 · Cited by 634

Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos.Preprint

Ludwig, T. E., Chapman, D. L., Papaioannou, V. E., & Efstratiadis, A. (1997) · Genes & Development · doi:10.1101/gad.11.10.1226 · Cited by 539

BRCA1 and its toolbox for the maintenance of genome integrity

Huen, M. S. Y., Sy, S. M.-H., & Chen, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2831 · Cited by 517

Playing the End Game: DNA Double-Strand Break Repair Pathway Choice

Chapman, J. R., Taylor, M. R. G., & Boulton, S. J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.07.029 · Cited by 1,728

Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins

Prakash, R., Zhang, Y., Feng, W., & Jasin, M. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016600 · Cited by 869

Accurate classification of BRCA1 variants with saturation genome editing

Findlay, G. M., Daza, R. M., Martin, B., Zhang, M. D., Leith, A. P., Gasperini, M., Janizek, J. D., Huang, X., Starita, L. M., & Shendure, J. (2018) · Nature · doi:10.1038/s41586-018-0461-z · Cited by 843

The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance

Bouwman, P., & Jonkers, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3342 · Cited by 615

Regulation of DNA Damage Responses by Ubiquitin and SUMO

Jackson, S. P., & Durocher, D. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.017 · Cited by 601

Genetics and biology of pancreatic ductal adenocarcinoma

Ying, H., Dey, P., Yao, W., Kimmelman, A. C., Draetta, G. F., Maitra, A., & DePinho, R. A. (2016) · Genes & Development · doi:10.1101/gad.275776.115 · Cited by 527

Ubiquitin ligases in oncogenic transformation and cancer therapy

Senft, D., Qi, J., & Ronai, Z. A. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.105 · Cited by 499

Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance

Pettitt, S. J., Krastev, D. B., Brandsma, I., Dréan, A., Song, F., Aleksandrov, R., Harrell, M. I., Menon, M. R., Brough, R., Campbell, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03917-2 · Cited by 463

Hereditary breast and ovarian cancer: new genes in confined pathways

Nielsen, F. C., van Overeem Hansen, T., & Sørensen, C. S. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.72 · Cited by 367

Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers

Schwertman, P., Bekker‐Jensen, S., & Mailand, N. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.58 · Cited by 368

The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication

Tarsounas, M., & Sung, P. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0218-z · Cited by 389

DNA double-strand break repair pathway choice and cancer

Aparicio, T., Baer, R., & Gautier, J. (2014) · DNA Repair · doi:10.1016/j.dnarep.2014.03.014 · Cited by 347

Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer

Chen, C.-C., Feng, W., Lim, P. X., Kass, E. M., & Jasin, M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050502 · Cited by 323

How cells ensure correct repair of DNA double-strand breaks

Her, J., & Bunting, S. F. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm118.000371 · Cited by 326

Massively Parallel Functional Analysis of BRCA1 RING Domain Variants

Starita, L. M., Young, D. L., Islam, M. M., Kitzman, J. O., Gullingsrud, J., Hause, R. J., Fowler, D. M., Parvin, J. D., Shendure, J., & Fields, S. (2015) · Genetics · doi:10.1534/genetics.115.175802 · Cited by 300

Cancer Suppression by the Chromosome Custodians, BRCA1 and BRCA2

Venkitaraman, A. R. (2014) · Science · doi:10.1126/science.1252230 · Cited by 300

Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance

Johnson, N., Johnson, S. F., Yao, W., Li, Y.-C., Choi, Y.-E., Bernhardy, A. J., Wang, Y., Capelletti, M., Sarosiek, K. A., Moreau, L. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305170110 · Cited by 267

BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance

Drost, R., Bouwman, P., Rottenberg, S., Boon, U., Schut, E., Klarenbeek, S., Klijn, C. N., van der Heijden, I., van der Gulden, H. M. L., Wientjens, E., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.014 · Cited by 266

The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry

Kahrilas, P. J., & Boeckxstaens, G. E. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 236

Histone ubiquitination in the DNA damage response

Uckelmann, M., & Sixma, T. K. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.06.011 · Cited by 222

DNA Double-Strand Break Resection Occurs during Non-homologous End Joining in G1 but Is Distinct from Resection during Homologous Recombination

Diemer-Biehs, R., Steinlage, M., Barton, O., Juhász, S., Künzel, J., Spies, J., Shibata, A., Jeggo, P. A., & Löbrich, M. (2017) · Molecular Cell · doi:10.1016/j.molcel.2016.12.016 · Cited by 224

H4K20me0 recognition by BRCA1–BARD1 directs homologous recombination to sister chromatids

Nakamura, K., Saredi, G., Becker, J. R., Foster, B. M., Nguyen, N. V., Beyer, T. E., Cesa, L. C., Faull, P. A., Lukauskas, S., Frimurer, T. M., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0282-9 · Cited by 206

A meta-analysis of reversion mutations in BRCA genes identifies signatures of DNA end-joining repair mechanisms driving therapy resistance

Tobalina, L., Armenia, J., Irving, E., O’Connor, M. J., & Forment, J. V. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.10.470 · Cited by 196

BRCA 1, a ‘complex’ protein involved in the maintenance of genomic stability

Savage, K. I., & Harkin, D. P. (2014) · FEBS Journal · doi:10.1111/febs.13150 · Cited by 183

What We Have Learned About Pancreatic Cancer From Mouse Models

Pérez-Mancera, P. A., Guerra, C. E., Barbacid, M., & Tuveson, D. A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.002 · Cited by 178

BRCA1 Is a Histone-H2A-Specific Ubiquitin Ligase

Kalb, R., Mallery, D. L., Larkin, C., Huang, J. T.-J., & Hiom, K. J. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.025 · Cited by 164

The proteasomal de‐ubiquitinating enzyme POH1 promotes the double‐strand DNA break response

Butler, L. R., Densham, R. M., Jia, J., Garvin, A. J., Stone, H. R., Shah, V., Weekes, D. B., Festy, F., Beesley, J. F. J., & Morris, J. R. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.232 · Cited by 168

Molecular Pathways: How Can BRCA-Mutated Tumors Become Resistant to PARP Inhibitors?

Bouwman, P., & Jonkers, J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0225 · Cited by 166

Mechanisms of BRCA1 Tumor Suppression

Silver, D. P., & Livingston, D. M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0221 · Cited by 159

A protein interaction landscape of breast cancer

Kim, M., Park, J., Bouhaddou, M., Kim, K., Rojc, A., Modak, M., Soucheray, M., McGregor, M., O’Leary, P. C., Wolf, D. M., et al. (2021) · Science · doi:10.1126/science.abf3066 · Cited by 160

Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer

Domchek, S. M., Tang, J.-B., Stopfer, J. E., Lilli, D. R., Hamel, N., Tischkowitz, M. D., Monteiro, Á. N. A., Messick, T. E., Powers, J., Yonker, A., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0421 · Cited by 152

Ubiquitylation, neddylation and the DNA damage response

Brown, J. S., & Jackson, S. P. (2015) · Open Biology · doi:10.1098/rsob.150018 · Cited by 155

MG53-mediated cell membrane repair protects against acute kidney injury

Duann, P., Li, H., Lin, P., Tan, T., Wang, Z., Chen, K., Zhou, X., Gumpper, K., Hua Zhu, C., Ludwig, T., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010755 · Cited by 143

A High-Throughput Functional Complementation Assay for Classification of BRCA1 Missense Variants

Bouwman, P., van der Gulden, H., van der Heijden, I., Drost, R., Klijn, C. N., Prasetyanti, P., Pieterse, M., Wientjens, E., Seibler, J., Hogervorst, F. B. L., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0094 · Cited by 140

Genetically Engineered Mouse Models of Pancreatic Cancer

Westphalen, C. B., & Olive, K. P. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31827ab4c4 · Cited by 140

BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1

Drost, R., Dhillon, K. K., van der Gulden, H. M. L., van der Heijden, I., Brandsma, I., Cruz, C., Chondronasiou, D., Castroviejo‐Bermejo, M., Boon, U., Schut, E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci70196 · Cited by 142

Biochemical mechanism of DSB end resection and its regulation

Daley, J. M., Niu, H., Miller, A. S., & Sung, P. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.04.015 · Cited by 141

The Ubiquitin Proteasome Pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis.

Tu, Y., Chen, C., Pan, J., Xu, J., Zhou, Z., & Wang, C. (2012) · Europe PMC (PubMed Central) · Cited by 129

A guide for functional analysis ofBRCA1variants of uncertain significance

Millot, G. A., Carvalho, M. A., Caputo, S. M., Vreeswijk, M. P. G., Brown, M. A., Webb, M., Rouleau, É., Neuhausen, S. L., Hansen, T. V. O., Galli, A., et al. (2012) · Human Mutation · doi:10.1002/humu.22150 · Cited by 140

Functional Assays for Analysis of Variants of Uncertain Significance inBRCA2

Guidugli, L., Carreira, A., Caputo, S. M., Ehlén, Å., Galli, A., Monteiro, Á. N. A., Neuhausen, S. L., Hansen, T. V. O., Couch, F. J., & Vreeswijk, M. P. G. (2013) · Human Mutation · doi:10.1002/humu.22478 · Cited by 132

A Multiplex Homology-Directed DNA Repair Assay Reveals the Impact of More Than 1,000 BRCA1 Missense Substitution Variants on Protein Function

Starita, L. M., Islam, M. M., Banerjee, T., Adamovich, A. I., Gullingsrud, J., Fields, S., Shendure, J., & Parvin, J. D. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.07.016 · Cited by 121

Co-operation of BRCA1 and POH1 relieves the barriers posed by 53BP1 and RAP80 to resection

Kakarougkas, A., Ismail, A., Katsuki, Y., Freire, R., Shibata, A., & Jeggo, P. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt802 · Cited by 121

Links between genome integrity and BRCA1 tumor suppression

Covington, M. L., & Greenberg, R. A. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.06.007 · Cited by 119

CtIP-mediated resection is essential for viability and can operate independently of BRCA1

Polato, F., Callén, E., Wong, N., Faryabi, R. B., Bunting, S. F., Chen, H. T., Kozak, M., Kruhlak, M. J., Reczek, C. R., Lee, W., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131939 · Cited by 123

The role of BRCA1 in DNA double-strand repair: Past and present

Caestecker, K. W., & Van de Walle, G. R. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.11.013 · Cited by 108

RING domain–deficient BRCA1 promotes PARP inhibitor and platinum resistance

Wang, Y., Krais, J. J., Bernhardy, A. J., Nicolas, É., Cai, K. Q., Harrell, M. I., Kim, H. H., George, E. M., Swisher, E. M., Simpkins, F. A., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87033 · Cited by 110

Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance

Anantha, R. W., Simhadri, S. R., Foo, T. K., Miao, S. Y., Liu, J., Shen, Z., Ganesan, S., & Xia, B. (2017) · eLife · doi:10.7554/elife.21350 · Cited by 109

USP48 restrains resection by site-specific cleavage of the BRCA1 ubiquitin mark from H2A

Uckelmann, M., Densham, R. M., Baas, R., Winterwerp, H. H. K., Fish, A., Sixma, T. K., & Morris, J. R. (2018) · Nature Communications · doi:10.1038/s41467-017-02653-3 · Cited by 105

BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance

Nacson, J., Krais, J. J., Bernhardy, A. J., Clausen, E., Feng, W., Wang, Y., Nicolas, É., Cai, K. Q., Tricarico, R., Hua, X., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.086 · Cited by 99

Skp2 is a Promising Therapeutic Target in Breast Cancer

Wang, Z. P., Fukushima, H., Inuzuka, H., Wan, L., Liu, P., Gao, D., Sarkar, F. H., & Wei, W. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2011.00057 · Cited by 96

Deciphering the BRCA1 Tumor Suppressor Network

Jiang, Q., & Greenberg, R. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.667931 · Cited by 96

Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms

de la Hoya, M., Soukarieh, O., López‐Perolio, I., Vega, A. I., Walker, L. C., van Ierland, Y., Baralle, D., Santamariña, M., Lattimore, V., Wijnen, J., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw094 · Cited by 96

SETDB1, HP1 and SUV39 promote repositioning of 53BP1 to extend resection during homologous recombination in G2 cells

Alagöz, M., Katsuki, Y., Ogiwara, H., Ogi, T., Shibata, A., Kakarougkas, A., & Jeggo, P. A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv722 · Cited by 93

BRCA1/BARD1 site-specific ubiquitylation of nucleosomal H2A is directed by BARD1

Witus, S. R., Burrell, A. L., Farrell, D. P., Kang, J., Wang, M., Hansen, J. M., Pravat, A., Tuttle, L. M., Stewart, M. D., Brzović, P. S., et al. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-00556-4 · Cited by 85

The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection

Billing, D. L., Horiguchi, M., Wu-Baer, F., Taglialatela, A., Leuzzi, G., Nanez, S. A., Jiang, W., Zha, S., Szabolcs, M. J., Lin, C., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.08.016 · Cited by 86

Homologous Recombination DNA Repair Genes Play a Critical Role in Reprogramming to a Pluripotent State

Gonzãlez, F., Georgieva, D., Vanoli, F., Shi, Z., Stadtfeld, M., Ludwig, T., Jasin, M., & Huangfu, D. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.02.005 · Cited by 86

BRCA1 Suppresses Epithelial-to-Mesenchymal Transition and Stem Cell Dedifferentiation during Mammary and Tumor Development

Bai, F., Chan, H. L., Scott, A., Smith, M. D., Fan, C., Herschkowitz, J. I., Perou, C. M., Livingstone, A. S., Robbins, D. J., Capobianco, A. J., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1119 · Cited by 84

New concepts on BARD1: Regulator of BRCA pathways and beyond

Irminger‐Finger, I., Ratajska, M., & Pilyugin, M. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.12.008 · Cited by 85

A Fifth of the Protein World: Rossmann-like Proteins as an Evolutionarily Successful Structural unit

Medvedev, K. E., Kinch, L. N., Schaeffer, R. D., Pei, J., & Grishin, N. V. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.166788 · Cited by 86

The interaction between CtIP and BRCA1 is not essential for resection-mediated DNA repair or tumor suppression

Reczek, C. R., Szabolcs, M. J., Stark, J. M., Ludwig, T., & Baer, R. J. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201302145 · Cited by 89

Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions

Alkema, N. G., Wisman, G. B. A., van der Zee, A. G. J., van Vugt, M. A. T. M., & de Jong, S. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.11.005 · Cited by 84

Cell cycle-dependent inhibition of 53BP1 signaling by BRCA1

Feng, L., Li, N., Li, Y., Wang, J., Gao, M., Wang, W., & Chen, J. (2015) · Cell Discovery · doi:10.1038/celldisc.2015.19 · Cited by 86

BRCA1 tumor suppressor network: focusing on its tail

Wang, B. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-6 · Cited by 78

Structure of BRCA1-BRCT/Abraxas Complex Reveals Phosphorylation-Dependent BRCT Dimerization at DNA Damage Sites

Wu, Q., Paul, A., Su, D., Mehmood, S., Foo, T. K., Ochi, T., Bunting, E. L., Xia, B., Robinson, C. V., Wang, B., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2015.12.017 · Cited by 80

Detection of single amino acid mutation in human breast cancer by disordered plasmonic self-similar chain

Coluccio, M. L., Gentile, F., Das, G., Nicastri, A., Perri, A., Candeloro, P., Perozziello, G., Zaccaria, R. P., Gongora, J. S. T., Alrasheed, S., et al. (2015) · Science Advances · doi:10.1126/sciadv.1500487 · Cited by 75

New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer

Han, Y., Yu, X., Li, S., Tian, Y. E., & Liu, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.578095 · Cited by 73

Reverse the Resistance to PARP Inhibitors

Kim, Y., Kim, A., Sharip, A., Sharip, A., Jiang, J., Yang, Q., & Xie, Y. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.17240 · Cited by 75

Mouse models of BRCA1 and their application to breast cancer research

Dine, J. L., & Deng, C. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9403-7 · Cited by 82

Dysregulation of ubiquitin ligases in cancer

Qi, J., & Ronai, Z. A. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.09.001 · Cited by 69

BRCA1 targets G2/M cell cycle proteins for ubiquitination and proteasomal degradation

Shabbeer, S., Omer, D., Berneman, D., Weitzman, O., Alpaugh, A., Pietraszkiewicz, A. A., Metsuyanim, S., Shainskaya, A., Papa, M. Z., & Yarden, R. I. (2012) · Oncogene · doi:10.1038/onc.2012.522 · Cited by 71

BRCA1 in the DNA damage response and at telomeres

Rosen, E. M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00085 · Cited by 68

Wip1 Controls Global Heterochromatin Silencing via ATM/BRCA1-Dependent DNA Methylation

Filipponi, D., Müller, J., Emelyanov, A., & Bulavin, D. V. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.022 · Cited by 70

Nonenzymatic Polymerization of Ubiquitin: Single‐Step Synthesis and Isolation of Discrete Ubiquitin Oligomers

Trang, V. H., Valkevich, E. M., Minami, S., Chen, Y., Ge, Y., & Strieter, E. R. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201207171 · Cited by 68

RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage

Krais, J. J., Wang, Y., Patel, P., Basu, J. M., Bernhardy, A. J., & Johnson, N. (2021) · Nature Communications · doi:10.1038/s41467-021-25346-4 · Cited by 66

A DNA-Damage Selective Role for BRCA1 E3 Ligase in Claspin Ubiquitylation, CHK1 Activation, and DNA Repair

Sato, K., Sundaramoorthy, E., Rajendra, E., Hattori, H., Jeyasekharan, A. D. D., Ayoub, N., Schiess, R., Aebersold, R. H., Nishikawa, H., Sedukhina, A. S., et al. (2012) · Current Biology · doi:10.1016/j.cub.2012.07.034 · Cited by 67

ATM loss leads to synthetic lethality in BRCA1 BRCT mutant mice associated with exacerbated defects in homology-directed repair

Chen, C.-C., Kass, E. M., Yen, W.-F., Ludwig, T., Moynahan, M. E., Chaudhuri, J., & Jasin, M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706392114 · Cited by 64

BRCA1 Mutations in Cancer: Coordinating Deficiencies in Homologous Recombination with Tumorigenesis

Krais, J. J., & Johnson, N. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1830 · Cited by 66

Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation

Bai, F., Smith, M. D., Chan, H. L., & Pei, X.-H. (2012) · Oncogene · doi:10.1038/onc.2012.293 · Cited by 64

BRCA1 and Oxidative Stress

Yi, Y. W., Kang, H. J., & Bae, I. (2014) · Cancers · doi:10.3390/cancers6020771 · Cited by 65

BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance

Wang, Y., Bernhardy, A. J., Nacson, J., Krais, J. J., Tan, Y., Nicolas, É., Radke, M. R., Handorf, E., Llop‐Guevara, A., Balmañà, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13530-6 · Cited by 60

RNF8 Regulates Assembly of RAD51 at DNA Double-Strand Breaks in the Absence of BRCA1 and 53BP1

Nakada, S., Yonamine, R. M., & Matsuo, K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1057 · Cited by 58

BRCA1 Mutational Complementation Induces Synthetic Viability

Nacson, J., Marcantonio, D. D., Wang, Y., Bernhardy, A. J., Clausen, E., Hua, X., Cai, K. Q., Martı́nez, E., Feng, W., Callén, E., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.006 · Cited by 53

Characterization of BRCA1 Protein Targeting, Dynamics, and Function at the Centrosome

Brodie, K. M., & Henderson, B. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.327296 · Cited by 62

BRCA1 and Its Network of Interacting Partners

Christou, C. M., & Kyriacou, K. C. (2013) · Biology · doi:10.3390/biology2010040 · Cited by 58

BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site

Kang, H. J., Yi, Y. W., Kim, H. J., Hong, Y. B., Seong, Y., & Bae, I. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.78 · Cited by 57

BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes

Stewart, M. D., Zelin, E., Dhall, A., Walsh, T., Upadhyay, E., Corn, J. E., Chatterjee, C., King, M., & Klevit, R. E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715467115 · Cited by 55

The BRCA1 Ubiquitin ligase function sets a new trend for remodelling in DNA repair

Densham, R. M., & Morris, J. R. (2016) · Nucleus · doi:10.1080/19491034.2016.1267092 · Cited by 55

The BRCA1/BARD1 ubiquitin ligase and its substrates

Witus, S. R., Stewart, M. D., & Klevit, R. E. (2021) · Biochemical Journal · doi:10.1042/bcj20200864 · Cited by 54

Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair

Wang, M., Li, W., Tomimatsu, N., Yu, C. H., Ji, J., Alejo, S., Witus, S. R., Alimbetov, D. S., Fitzgerald, O. R., Wu, B., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.09.015 · Cited by 50

Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors

Yamamoto, K., Wang, J., Sprinzen, L., Xu, J., Haddock, C. J., Li, C., Lee, B. J., Loredan, D. G., Jiang, W., Vindigni, A., et al. (2016) · eLife · doi:10.7554/elife.14709 · Cited by 53

Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays

Sadeghi, F., Asgari, M., Matloubi, M., Ranjbar, M., Yousefi, N. K., Azari, T., & Zaki‐Dizaji, M. (2020) · Biological Procedures Online · doi:10.1186/s12575-020-00133-5 · Cited by 55

A cGAS-mediated mechanism in naked mole-rats potentiates DNA repair and delays aging

Chen, Y., Chen, Z., Wang, H., Cui, Z., Li, K.-L., Song, Z., Chen, L., Sun, X., Xu, X., Zhang, Y., et al. (2025) · Science · doi:10.1126/science.adp5056 · Cited by 53

Genetic ablation of Smoothened in pancreatic fibroblasts increases acinar–ductal metaplasiaPreprint

Liu, X., Pitarresi, J. R., Cuitiño, M. C., Kladney, R. D., Woelke, S. A., Sizemore, G. M., Nayak, S. G., Egriboz, O., Schweickert, P. G., Yu, L., et al. (2016) · Genes & Development · doi:10.1101/gad.283499.116 · Cited by 50

Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation

Monteiro, Á. N. A., Bouwman, P., Kousholt, A. N., Eccles, D., Millot, G. A., Masson, J., Schmidt, M. K., Sharan, S. K., Scully, R., Wiesmüller, L., et al. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106368 · Cited by 49

Writers, Readers, and Erasers of Histone Ubiquitylation in DNA Double-Strand Break Repair

Smeenk, G., & Mailand, N. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00122 · Cited by 52

BRCA1 promotes the ubiquitination of PCNA and recruitment of translesion polymerases in response to replication blockade

Tian, F., Sharma, S., Zou, J., Lin, S., Wang, B., Rezvani, K. S., Wang, H., Parvin, J. D., Ludwig, T., Canman, C. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306534110 · Cited by 48

Pathways for Genome Integrity in G2 Phase of the Cell Cycle

Kousholt, A. N., Menzel, T., & Sørensen, C. S. (2012) · Biomolecules · doi:10.3390/biom2040579 · Cited by 49

53BP1 ablation rescues genomic instability in mice expressing ‘RING‐less’ BRCA1

Li, M., Cole, F., Patel, D. S., Misenko, S. M., Her, J., Malhowski, A. J., Alhamza, A., Zheng, H., Baer, R. J., Ludwig, T., et al. (2016) · EMBO Reports · doi:10.15252/embr.201642497 · Cited by 47

Untangling the crosstalk between BRCA1 and R-loops during DNA repair

Alonso, M. S. M., & Noordermeer, S. M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab178 · Cited by 45

Analysis of Induced Pluripotent Stem Cells from a BRCA1 Mutant Family

Soyombo, A. A., Wu, Y., Kolski, L., Rios, J. J., Rakheja, D., Chen, A. P., Kehler, J., Hampel, H., Coughran, A. J., & Ross, T. S. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.08.004 · Cited by 49

BRCA1 Tumor Suppression Requires the BRCT Domain

(2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-rw111011ol-16

The Role of CtIP in BRCA1-Mediated Tumor Suppression

Reczek, C. R. (2012) · doi:10.7916/d82j68z9

BRCA1’s Phosphorylation Dependent Interaction with Abraxas, BACH1, and CtIP: Elucidation of the BRCA1 Mediated DNA Damage Response

Chang, K. Y. (2014) · The Knowledge Bank (The Ohio State University)

Ubiquitination Activity Not Required

VanHook, A. M. (2011) · Science Signaling · doi:10.1126/scisignal.4197ec305

BRCA1 tumor suppressor network: focusing on its tail

Wang, B. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-6 · Cited by 78